source
- Kura Oncology launches Caspian Therapeutics to develop menin-inhibitor diabetes drug with $50M fundingKura Oncology has spun out a new biotech called Caspian Therapeutics to focus on menin inhibitors for diabetes and other cardiometabolic diseases. The company’s lead candidate, code-named KO-7246,…
- FDA appoints permanent heads of CDER and CBER, adding AI deputy roleThe Trump administration announced permanent appointments to two key FDA centers after a period of turnover. Michael Davis, who had been acting director of the Center for Drug Evaluation and Resea…